Skip to main content

Table 2 Characteristics of medications use depending on the presence or the absence of metabolic syndrome

From: Association between the intima-media thickness of the extracranial carotid arteries and metabolic syndrome in ethnic Kyrgyzs

Parameters Men Women
MS + (n = 36) MS - (n = 33) MS + (n = 47) MS - (n = 28)
ACEI, n (%) 5 (15,2) 3 (8,3) 8 (28,6) 4 (8,5)*
Amlodipine, n (%) 0 (0) 1 (2,8) 1 (3,6) 1 (2,1)
Other Ca antagonists (Verapamil, Nifedipine), n (%) 1 (3,03) 0 (0) 1 (3,6) 0 (0)
Beta blockers (atenolol), n (%) 3 (9,1) 2 (5,6) 1 (3,6) 3 (6,4)
Indapamide, n (%) 1 (3,03) 0 (0) 0 (0) 0 (0)
Oral glucose lowering drug (glibenclamide), n (%) 2 (6,1) 0 (0) 1 (3,6) 0 (0)
  1. ACEI angiotensin converter enzyme inhibitors, MS metabolic syndrome; * - p < 0.05 in women